Andrew M. Peters

Andrew M. Peters

Auto-generated profile, based on publicly available information

Andrew M. Peters

University of Nottingham

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Neuron
Verified
Journal Article
Open access
PSPetroc Sumner
Petroc Sumner
PNParashkev Nachev
Parashkev Nachev
PMPeter Morris
Peter Morris
APAndrew M. Peters
Andrew M. Peters
SJStephen R. Jackson
Stephen R. Jackson
MHMasud Husain
Masud Husain
Within the medial frontal cortex, the supplementary eye field (SEF), supplementary motor area (SMA), and pre-SMA have been implicated in the control of voluntary action, especially during motor sequences or tasks involving rapid choices between competing response plans. However, the precise roles of these areas remain controversial. Here, we study two extremely rare patients with microlesions of the SEF and SMA to demonstrate that these areas are critically involved in unconscious and involuntary motor control. We employed masked-prime stimuli that evoked automatic inhibition in healthy people and control patients with lateral premotor or pre-SMA damage. In contrast, our SEF/SMA patients showed a complete reversal of the normal inhibitory effect--ocular or manual--corresponding to the functional subregion lesioned. These findings imply that the SEF and SMA mediate automatic effector-specific suppression of motor plans. This automatic mechanism may contribute to the participation of these areas in the voluntary control of action.

1 October 2009 in NeuroImage
Verified
Journal Article
Closed access
WZWietske van der Zwaag
Wietske van der Zwaag
SFSusan Francis
Susan Francis
KHKay Head
Kay Head
APAndrew Peters
Andrew Peters
PGPenny Gowland
Penny Gowland
RBRichard Bowtell
Richard Bowtell

8 February 2008 in Magnetic Resonance Materials in Physics, Biology and Medicine
Verified
Journal Article
Closed access
PDF file
PWP. J. Wright
P. J. Wright
OMO. E. Mougin
O. E. Mougin
JTJ. J. Totman
J. J. Totman
APA. M. Peters
A. M. Peters
MBM. J. Brookes
M. J. Brookes
PGP. A. Gowland
P. A. Gowland

1 July 2007 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
APAndrew M. Peters
Andrew M. Peters
MBMatthew J. Brookes
Matthew J. Brookes
FHFrank G. Hoogenraad
Frank G. Hoogenraad
PGPenny A. Gowland
Penny A. Gowland
SFSusan Francis
Susan Francis
RBRichard Bowtell
Richard Bowtell

1 February 2008 in NeuroImage
Verified
Journal Article
Closed access
MBMatthew J. Brookes
Matthew J. Brookes
JVJiri Vrba
Jiri Vrba
SRStephen E. Robinson
Stephen E. Robinson
CSClaire M. Stevenson
Claire M. Stevenson
APAndrew M. Peters
Andrew M. Peters
PMPeter G. Morris
Peter G. Morris

10 October 2011 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
ALAshley K. Lotfipour
Ashley K. Lotfipour
SWSamuel Wharton
Samuel Wharton
SSStefan T. Schwarz
Stefan T. Schwarz
VGV. Gontu
V. Gontu
ASAndreas Schäfer
Andreas Schäfer
NBNin P.S. Bajaj
Nin P.S. Bajaj
Purpose: To determine if tissue magnetic susceptibility is a more direct marker of tissue iron content than other MR markers of iron. This study presents the first quantitative, in vivo measurements of the susceptibility of the substantia nigra in patients with Parkinson's disease.Materials and Methods: Nine patients and 11 controls were studied at 7 Tesla. Susceptibility maps were created by inverting the filtered phase maps associated with T2* weighted images.Results: On average, patients showed an increase in susceptibility of the pars compacta compared with controls, which correlates with the predicted increase in brain iron in Parkinson's disease. A rostral–caudal gradient in susceptibility was also observed in controls and patients.Conclusion: Susceptibility mapping may provide a new tool for studying the development of Parkinson's disease. J. Magn. Reson. Imaging 2012;35:48‐55.